Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Retained Earnings (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Retained Earnings over the past 15 years, most recently at -$205.2 million for Q2 2025.

  • Quarterly results put Retained Earnings at -$205.2 million for Q2 2025, down 23.25% from a year ago — trailing twelve months through May 2025 was -$205.2 million (down 23.25% YoY), and the annual figure for FY2025 was -$205.2 million, down 23.25%.
  • Retained Earnings for Q2 2025 was -$205.2 million at Lifecore Biomedical, Inc. \De\, down from -$204.1 million in the prior quarter.
  • Over the last five years, Retained Earnings for LFCR hit a ceiling of $28.4 million in Q3 2021 and a floor of -$205.2 million in Q2 2025.
  • Median Retained Earnings over the past 5 years was -$149.3 million (2023), compared with a mean of -$110.1 million.
  • Biggest five-year swings in Retained Earnings: soared 51.64% in 2021 and later tumbled 66085.31% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Retained Earnings stood at -$10.1 million in 2021, then tumbled by 915.67% to -$102.7 million in 2022, then plummeted by 70.39% to -$175.1 million in 2023, then fell by 9.36% to -$191.5 million in 2024, then dropped by 7.2% to -$205.2 million in 2025.
  • The last three reported values for Retained Earnings were -$205.2 million (Q2 2025), -$204.1 million (Q1 2025), and -$191.5 million (Q4 2024) per Business Quant data.